Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 940 results for "cipla india"

Cipla signs deal to set up first biosimilars unit in South Africa

Dube TradePort secures R1.3bn pharmaceuticals investment

Trade and Industry Minister Dr Rob Davies has signed a memorandum of agreement with Indian pharmaceutical company Cipla Biotec on the commercial terms of a R1.3-billion investment to establish Cipla Biotec's new biosimilars manufacturing facility, ... Engineering News, 5 days ago

25 images for cipla india

DeshGujarat, 2 days ago, 1 week ago, 3 weeks ago, 1 week ago, 1 week ago
Deccan Chronicle, 3 weeks ago
Financial Express, 3 weeks ago
Pharmaceutical, 3 weeks ago
Reuters India, 2 months ago
Financial Express, 2 months ago

Cipla drops after unfavorable ruling by Supreme Court

Cipla fell 2.01% to Rs 583.10 at 15:13 IST on BSE after Supreme Court decided in favour of Union of India in an appeal filed against the company and others arising out of the judgement of the Allahabad High Court. The announcement was made during ...
 Capital Market2 days ago Supreme Court upholds centre's notification capping retail price of drugs  Livemint.com2 days ago Cipla slips 2%  India Infoline2 days ago Cipla slips 2% after losing appeal in Supreme Court  India Infoline2 days ago

Sensex down 44 points amid cautious trades; ITC, Cipla gain

With stocks swinging between gains and losses amid alternate bouts of buying and selling, the key Indian stock indices Sensex and the Nifty50 are struggling to make any headway into positive territory today. Global cues are weak and there are no big positive ...
 Sify1 month ago Live Stock Market Updates - Sensex, Nifty flat; Realty, Banking gain  India Infoline1 week ago Sensex looks headed for flat close  Sify1 week ago Sensex, Nifty steady ahead of RBI policy; ONGC up four pct  Yahoo! India2 weeks ago

Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016 (SCRIPCODE: 500087)

Cities Business & Finance ACCORD FINTECH BSE Online News India, Oct. 21 -- Cipla Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation ...
 HT Syndication2 days ago

Cipla seeks to boost India revenue with new drugs

MUMBAI (NewsRise) - Indian drug maker Cipla aims to boost its revenue from home with a slew of new launches and partnerships with other pharmaceutical companies, even as it contends with price controls and ban on certain products. India has ...
 Nikkei Asian Review3 weeks ago Opening bell | TCS earnings today; Cipla, IndusInd Bank, Essar Oil in the news  Livemint.com1 week ago R&D SPENDING BY PHARMA COS  PharmaBiz5 days ago Cipla aims to reach $1bn India sales through tie-ups  Economic Times3 weeks ago

Sensex, Nifty still in green; Wipro, Bharti, Cipla gain 1%

GAIL, ONGC, Wipro, Bharti Airtel and Cipla are top gainers while Coal India, LT, MM, Axis Bank and HUL are losers in the Sensex.
 Money Control2 weeks ago Sensex ends 521 points up on global cues  Sify5 days ago Sensex, Nifty steady; GAIL ONGC gain 4%, LT down 1%  Money Control2 weeks ago Sensex ends 377 points up on global cues, strong automobile sales data  Sify2 weeks ago
Financial Express

Pharma companies air concerns over plans to cap prices

Indian drugmakers, including Cipla, Dr. Reddy's and Sun Pharmaceutical, have expressed concerns over plans by the government to cap prices on products for which there are no market data, as reported The Times of India Thursday. If finalised, ...
 FirstWord Pharma1 month ago Reviving APIs  Express Pharma1 week ago Domestic pharma firms facing challenging environment: Cipla  Times of India3 weeks ago Indian Pharmaceutical Market - Leading Domestic Companies 2015  Before It's News5 days ago
Money Control

Sensex, Nifty open in green; Axis drags, Reliance Aurobindo up

Reliance, Bharti Airtel, ONGC, Tata Motors and LT are top gainers while Axis Bank, Cipla, Coal India, Infosys and Dr Reddy's Labs are losers in the Sensex.
 Money Control2 weeks ago Sensex up over 100pts, Nifty above 8700; ITC, Tata Steel gain 1%  MSN India2 weeks ago Sensex, Nifty open in green  MSN India2 weeks ago Sensex, Nifty remain rangebound; Cipla, Coal India, Bharti drag  Money Control3 weeks ago

Sell Union Bank, ICICI Bank; buy Cipla: Ashwani Gujral

Ashwani Gujral of recommends selling Union Bank of India and ICICI Bank and buy Cipla.
 Money Control1 week ago Buy Cipla, Rallis India, UCO Bank: Ashwani Gujral  Money Control1 month ago Buy Cipla, Engineers India, Voltas: Ashwani Gujral  Money Control2 months ago Buy Cummins India, Cipla, JK Tyre: Ashwani Gujral  Money Control2 months ago

Cipla gets 4 US FDA observations for 3 facilities in Goa

Cipla, a fifth largest pharmaceutical company in India with net sales of Rs. 13,300 crore plus, has received four observations for its three manufacturing facilities at Goa. These observations were primarily procedural in nature and the company has ...
 PharmaBiz2 weeks ago Cipla gets 4 observations from US FDA for its three plants in Goa  Livemint.com3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less